Quality Investor

Cre8 Enterprise Limited

Rank #89Hypergrowth

CRE · Nasdaq · Industrials

Cre8 Enterprise Limited (CRE) — Rank #89 by gross profitability (GP/assets 0.47) · ROE 10.3% · Piotroski F-Score 5 / 9.

As-of 2026-09-15 · CIK 0002003977 · all metrics point-in-time as of the filing date.

About

Cre8 Enterprise Limited, through its subsidiaries, provides financial printing services in Hong Kong and the People's Republic of China.

Show more

The company offers concept creation and artwork design, typesetting, proofreading, translation, printing, binding, logistics arrangement, and uploading or making e-submissions for financial reports and compliance documents on the website of the Stock Exchange and media placements. It also provides technological support services; and website design, branding, and content creation services for marketing materials. In addition, the company disseminates and publishes announcements, circulars, financial reports, and industry news feeds through a website under the Cre8IR brand. It offers its services to listed companies, initial public offering applicants, and private companies in the finance and capital markets under the Cre8 brand name.

The company was founded in 2006 and is headquartered in Central, Hong Kong. Cre8 Enterprise Limited is a subsidiary of Cre8 Investments Limited.

Industry
Specialty Business Services
Sector
Industrials
Filer Category
Non-accelerated filerEmerging growth company

Price History

CRE-94.8% · -92.5% CAGRSPY+21.8% · +18.9% CAGR

Company Snapshot

P/S is the primary valuation lens — earnings are reinvested, not available for P/E.

Market Cap

$5.38M

P/E (annual)

1.0

P/S (annual)

0.0

P/B

0.1

P/OCF (annual)

0.5

Shareholder Yield

-3.3%

Employees

91

Industry

Specialty Business Services

Exchange

Nasdaq

Signal Flags

2 green1 yellow1 red
Revenue growth acceleratingGrowth rate increasing year over year
Deferred revenue growingRevenue and deferred revenue both growing — retention signal
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Operating margin decliningOperating margin lower than prior year

Quality Profile

Profitability

1/1 pass
GP / assets
0.47
Return on equity
10.3%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.26
Current ratio
1.57×
Net cash
$46.63M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue

Growth

1/2 pass
Revenue growth
26.1%
Piotroski F-Score
5 / 9
Share dilution
3.3%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

-64.4%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 3.3% — per-share value needs a total required return of -61.2% once share-count change is priced in.

vs. own 6-year median revenue growth: -9.9%

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

-65.1%

r = 10% (base)

-64.4%

r = 12%

-63.8%

Net debt / market cap: -902.0%

Note: current FCF margin is 1.5σ above its historical mean — implied growth may understate valuation risk if the margin reverts.

Base FCF: $10.8M3Y mean FCF: $8.2M

Revenue growth and the path to profitability (margin trend) are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.47

Primary signal (Novy-Marx).

Return on equity

10.3%

Gross margin

41.9%

Revenue growth (YoY)

26.1%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

10.5%

Revenue CAGR (5Y)

Earnings CAGR (3Y)

FCF CAGR (3Y)

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.26

Current ratio

1.57×

Quick ratio

1.43×

Net cash

$46.63M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$10.82M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.05

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

Stock-based comp intensity.

Piotroski F-Score

F-Score

5 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20222025
Value
Hypergrowth